Stocks
Illumina, Inc.ILMN
NASDAQHealthcareBiotechnology$118.94+2.92%
A global leader in DNA sequencing and array-based technologies, the company provides tools and services for genetic analysis across research, clinical, and applied markets. Its innovations in genomics have positioned it as a key player in precision medicine, making it a focal point for investors in the healthcare and biotechnology sectors.
Market Cap: $18.2B52W Range: $68.70 – $155.53
Congressional Interest in Illumina, Inc. (ILMN)
8 members of Congress have disclosed 50 trades in Illumina, Inc. (ILMN), a Healthcare company. The buy/sell breakdown shows 23 purchases versus 27 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
8
Buys
23
Sells
27
Who in Congress Is Trading ILMN?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-02-10 | Gilbert Cisneros | buy | $1K – $15K |
| 2026-01-29 | Rohit Khanna | buy | $1K – $15K |